Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Clinical research

Monoclonal antibody shows promise for chronic sinusitis

Study shows dupilumab therapy improves smell, sinus volume and inspiratory flow in patients with polyps.

A study shows that the monoclonal antibody dupilumab, which has previously shown efficacy in asthma and atopic dermatitis, could also treat chronic sinusitis with polyps (pictured)

Source: MathieuMD / Wikimedia Commons

Surgery for nasal polyps (pictured) could be avoided with a new drug called dupilumab

The standard treatment for chronic sinusitis with polyps is intranasal steroids but surgery is currently the only option for patients who fail to respond. 

A study published in JAMA (online, 2 February 2016)[1] shows that the monoclonal antibody dupilumab, which has previously shown efficacy in asthma and atopic dermatitis, could also treat chronic sinusitis with polyps. 

Researchers assigned 60 patients who were previously unresponsive to intranasal steroids to either subcutaneous dupilumab or placebo in addition to mometasone fuorate spray. 

After 16 weeks, patients assigned to the monoclonal antibody had a significant reduction in nasal polyp burden. Compared with patients in the placebo group, they also had significant improvements in smell, sinus volume, nasal inspiratory flow and quality of life. 

The researchers say that further studies will be needed to compare dupilumab to other treatments or surgery.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2016.20200671

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • A study shows that the monoclonal antibody dupilumab, which has previously shown efficacy in asthma and atopic dermatitis, could also treat chronic sinusitis with polyps (pictured)

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.